'Evaluatie van MTP-1 artrodese en (hemi)prothese als behandeling van MTP-1 artrose met behulp van gangbeeld analyse'

Clinical and Quantitative Gait Analysis in Patients with Hallux Rigidus treated with MTP-1 arthrodesis, hemiprosthesis or prosthesis.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22662

Enrollment

Registered

2017-10-24

Start date

2015-01-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Rigidus, First Metatarsophalangeal joint, Osteoarthritis

Interventions

- MTP1 arthrodesis - MTP1 hemiprosthesis - MTP1 prosthesis

Eligibility

Inclusion criteria

Inclusion criteria: - Degenerative Hallux Rigidus, radiologically confirmed - Failed conservative traject - Able to walk more than 100 meters barefoot

Exclusion criteria

Exclusion criteria: - Diabetes Mellitus - Reumatoid Arthritis - Gout - Total Knee Prosthesis - Total Hip Prosthesis - Arthrodesis of another joint in the foot of interest - Neurological condition resulting in an altered gait pattern - Fractur(s) of bone(s) in the lower extremities resulting in an altered gait pattern

Design outcomes

Primary

Measure	Time frame
Range of Motion (ROM) of the hallux-forefoot segment, forefoot-hindfoot segment and hindfoot-tibia segment	—

Secondary

Measure	Time frame
- Spatiotemporal parameters (gait velocity, stride length, stride width, step length, step time, cadence, stance time) - Plantar Pressure (Peak Pressure & Pressure Time Integral) - Clinical Functioning/Outcome (AOFAS-HMI, VAS-pain, MOXFQ, FFI, SF-36)	—

Contacts

Public ContactJasper Stevens

jasper.stevens@mumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)